Literature DB >> 14986263

Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?

Ajit Lalvani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14986263     DOI： 10.1086/381763

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  35 in total

1.  Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Authors:  Timothy Lahey; Siddharth Sheth; Mecky Matee; Robert Arbeit; C Robert Horsburgh; Lillian Mtei; Todd Mackenzie; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

2.  Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Authors:  Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

3.  Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice.

Authors:  T Meier; H-P Eulenbruch; P Wrighton-Smith; G Enders; T Regnath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

4.  Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.

Authors:  Yangjiong Xiao; Wei Sha; Zhaofeng Tian; Yingying Chen; Ping Ji; Qin Sun; Huiyu Wang; Shujun Wang; Yong Fang; Han-Li Wen; Hui-Min Zhao; Jie Lu; Heping Xiao; Xiao-Yong Fan; Hao Shen; Ying Wang
Journal:  J Mol Med (Berl)       Date:  2016-02-23       Impact factor: 4.599

5.  Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children.

Authors:  Tom G Connell; Mary-Ann Davies; Christine Johannisen; Kathryn Wood; Sandy Pienaar; Katalin A Wilkinson; Robert J Wilkinson; Heather J Zar; David Beatty; Mark P Nicol; Nigel Curtis; Brian Eley
Journal:  BMC Infect Dis       Date:  2010-05-27       Impact factor: 3.090

6.  Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.

Authors:  Timothy Lahey; Mecky Matee; Lillian Mtei; Muhammad Bakari; Kisali Pallangyo; C Fordham von Reyn
Journal:  BMC Infect Dis       Date:  2009-02-23       Impact factor: 3.090

7.  The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Authors:  Martine G Aabye; Pernille Ravn; George PrayGod; Kidola Jeremiah; Apolinary Mugomela; Maria Jepsen; Daniel Faurholt; Nyagosya Range; Henrik Friis; John Changalucha; Aase B Andersen
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

8.  In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.

Authors:  Ilaria Sauzullo; Fabio Mengoni; Miriam Lichtner; Anna Paola Massetti; Raffaella Rossi; Marco Iannetta; Raffaella Marocco; Cosmo Del Borgo; Fabrizio Soscia; Vincenzo Vullo; Claudio Maria Mastroianni
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

9.  Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis.

Authors:  Jean-Louis Herrmann; Marie Belloy; Raphael Porcher; Nancy Simonney; Rola Aboutaam; Muriel Lebourgeois; Joel Gaudelus; Laure De Losangeles; Katarina Chadelat; Pierre Scheinmann; Nicole Beydon; Brigitte Fauroux; Martine Bingen; Mustapha Terki; Dominique Barraud; Philippe Cruaud; Catherine Offredo; Agnes Ferroni; Patrick Berche; Didier Moissenet; Hoang Vuthien; Catherine Doit; Edouard Bingen; Philippe Henri Lagrange
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

10.  Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma.

Authors:  Jann-Yuan Wang; Chien-Hong Chou; Li-Na Lee; Hsiao-Leng Hsu; I-Shiow Jan; Po-Ren Hsueh; Pan-Chyr Yang; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.